Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Oxidative stress in asymptomatic subjects with hereditary hemochromatosis.

Literature DB >> 16955456

Oxidative stress in asymptomatic subjects with hereditary hemochromatosis.

Yukitaka Shizukuda, Charles D Bolan, Tammy T Nguyen, Gilberto Botello, Dorothy J Tripodi, Yu-Ying Yau, Myron A Waclawiw, Susan F Leitman, Douglas R Rosing.

Abstract

Entities: Disease

Mesh：

Substances：
Biomarkers

Year: 2007 PMID： 16955456 DOI： 10.1002/ajh.20743

Source DB: PubMed Journal: Am J Hematol ISSN： 0361-8609 Impact factor: 10.047

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

1. Changes in exercise capacity in subjects with cardiac asymptomatic hereditary hemochromatosis during a follow-up after 5 yrs.

Authors: Yukitaka Shizukuda; Kevin P Smith; Dorothy J Tripodi; Ross Arena; Yu-Ying Yau; Charles D Bolan; Myron A Waclawiw; Susan F Leitman; Douglas R Rosing
Journal: Am J Phys Med Rehabil Date: 2012-05 Impact factor: 2.159

2. Iron Overload or Oxidative Stress? Insight into a Mechanism of Early Cardiac Manifestations of Asymptomatic Hereditary Hemochromatosis Subjects with C282Y Homozygosity.

Authors: Yukitaka Shizukuda; Dorothy J Tripodi; Douglas R Rosing
Journal: J Cardiovasc Transl Res Date: 2016-06-08 Impact factor: 4.132

3. Incidence of cardiac arrhythmias in asymptomatic hereditary hemochromatosis subjects with C282Y homozygosity.

Authors: Yukitaka Shizukuda; Dorothy J Tripodi; Gloria Zalos; Charles D Bolan; Yu-Ying Yau; Susan F Leitman; Myron A Waclawiw; Douglas R Rosing
Journal: Am J Cardiol Date: 2011-12-22 Impact factor: 2.778

Review 4. Iron overload cardiomyopathy: better understanding of an increasing disorder.

Authors: Pradeep Gujja; Douglas R Rosing; Dorothy J Tripodi; Yukitaka Shizukuda
Journal: J Am Coll Cardiol Date: 2010-09-21 Impact factor: 24.094

5. Does oxidative stress modulate left ventricular diastolic function in asymptomatic subjects with hereditary hemochromatosis?

Authors: Yukitaka Shizukuda; Charles D Bolan; Dorothy J Tripodi; Vandana Sachdev; Tammy T Nguyen; Gilberto Botello; Yu-Ying Yau; Stanislav Sidenko; Ernst Inez; Mir I Ali; Myron A Waclawiw; Susan F Leitman; Douglas R Rosing
Journal: Echocardiography Date: 2009-08-28 Impact factor: 1.724

6. Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron).

Authors: Sim Yee Ong; Lara Dolling; Jeannette L Dixon; Amanda J Nicoll; Lyle C Gurrin; Michelle Wolthuizen; Erica M Wood; Greg J Anderson; Grant A Ramm; Katrina J Allen; John K Olynyk; Darrell Crawford; Jennifer Kava; Louise E Ramm; Paul Gow; Simon Durrant; Lawrie W Powell; Martin B Delatycki
Journal: BMJ Open Date: 2015-08-12 Impact factor: 2.692

7. Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents.

Authors: Etheresia Pretorius; Janette Bester; Natasha Vermeulen; Boguslaw Lipinski; George S Gericke; Douglas B Kell
Journal: PLoS One Date: 2014-01-09 Impact factor: 3.240